Published in Herz on May 01, 2003
Atypical presentation of a middle age male with severe hypertriglyceridaemia: a case report. J Med Case Rep (2007) 0.75
Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J (2007) 6.34
Effect of population-based screening on breast cancer mortality. Lancet (2011) 5.06
Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J (2013) 3.50
In silico fragmentation for computer assisted identification of metabolite mass spectra. BMC Bioinformatics (2010) 2.61
Ruling out coronary artery disease in primary care: development and validation of a simple prediction rule. CMAJ (2010) 2.37
Athlete's heart or hypertrophic cardiomyopathy? Clin Res Cardiol (2008) 2.32
Hyperlipidemia in patients with apolipoprotein E 2/2 phenotype: apolipoprotein A5 S19W mutation as a cofactor. Clin Chem (2004) 2.23
Prognostic significance of serum cholesterol levels in patients with idiopathic dilated cardiomyopathy. Eur Heart J (2005) 2.11
Incidence rates and predictors of major and minor depression in patients with heart failure. Int J Cardiol (2012) 2.05
Are we regionalized enough? Early-neonatal deaths in low-risk births by the size of delivery units in Hesse, Germany 1990-1999. Int J Epidemiol (2002) 1.82
Multiple sclerosis: brain-infiltrating CD8+ T cells persist as clonal expansions in the cerebrospinal fluid and blood. Proc Natl Acad Sci U S A (2004) 1.80
Risk of coronary artery disease associated with polymorphism of the cytochrome P450 epoxygenase CYP2J2. Circulation (2004) 1.73
Novel correlations between the genotype and the phenotype of hypertrophic and dilated cardiomyopathy: results from the German Competence Network Heart Failure. Eur J Heart Fail (2011) 1.70
A genome-wide association study identifies two loci associated with heart failure due to dilated cardiomyopathy. Eur Heart J (2011) 1.67
Occurrence of late gadolinium enhancement is associated with increased left ventricular wall stress and mass in patients with non-ischaemic dilated cardiomyopathy. Eur J Heart Fail (2011) 1.63
Method for aortic wall strain measurement with three-dimensional ultrasound speckle tracking and fitted finite element analysis. Ann Thorac Surg (2013) 1.56
Heart rate variability in patients with cardiac hypertrophy--relation to left ventricular mass and etiology. Am Heart J (2006) 1.55
Implantable defibrillator event rates in patients with idiopathic dilated cardiomyopathy, nonsustained ventricular tachycardia on Holter and a left ventricular ejection fraction below 30%. J Am Coll Cardiol (2002) 1.53
Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy: results of the Marburg Cardiomyopathy Study. Circulation (2003) 1.47
Increased osteoprotegerin serum levels in men with coronary artery disease. J Clin Endocrinol Metab (2003) 1.46
Chest pain in primary care: epidemiology and pre-work-up probabilities. Eur J Gen Pract (2009) 1.43
Isolated cardiac sarcoidosis associated with the expression of a splice variant coding for a truncated BTNL2 protein. Cardiology (2007) 1.42
Improved in vivo detection of cortical lesions in multiple sclerosis using double inversion recovery MR imaging at 3 Tesla. Eur Radiol (2010) 1.41
Non-compaction cardiomyopathy in an adult with hereditary spherocytosis. Eur J Heart Fail (2006) 1.41
2015 ESC Guidelines for the Diagnosis and Management of Pericardial Diseases. Rev Esp Cardiol (Engl Ed) (2015) 1.39
Genetic association study identifies HSPB7 as a risk gene for idiopathic dilated cardiomyopathy. PLoS Genet (2010) 1.37
Localization of osteoprotegerin, tumor necrosis factor-related apoptosis-inducing ligand, and receptor activator of nuclear factor-kappaB ligand in Mönckeberg's sclerosis and atherosclerosis. J Clin Endocrinol Metab (2004) 1.35
Impact of the 3D microenvironment on phenotype, gene expression, and EGFR inhibition of colorectal cancer cell lines. PLoS One (2013) 1.27
Accuracy of symptoms and signs for coronary heart disease assessed in primary care. Br J Gen Pract (2010) 1.13
Pharmacokinetic/pharmacodynamic modeling of in vitro activity of azithromycin against four different bacterial strains. Int J Antimicrob Agents (2006) 1.13
Identification of mutational hot spots in LMNA encoding lamin A/C in patients with familial dilated cardiomyopathy. Basic Res Cardiol (2008) 1.12
Magnetic resonance imaging in pericardial diseases. Indications and diagnostic value. Herz (2006) 1.11
Bacterial pericarditis: diagnosis and management. Am J Cardiovasc Drugs (2005) 1.10
Low serum levels of soluble RANK ligand are associated with the presence of coronary artery disease in men. Circulation (2003) 1.09
Preoperative and perioperative care for patients with suspected or established aortic stenosis facing noncardiac surgery. Chest (2005) 1.09
Public, expert and patients' opinions on preimplantation genetic diagnosis (PGD) in Germany. Reprod Biomed Online (2005) 1.07
Accuracy of general practitioners' assessment of chest pain patients for coronary heart disease in primary care: cross-sectional study with follow-up. Croat Med J (2010) 1.05
Does high field MRI allow an earlier diagnosis of multiple sclerosis? J Neurol (2008) 1.04
Osteoprotegerin (OPG) and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) levels in atherosclerosis. Atherosclerosis (2005) 1.02
Osteoprotegerin gene polymorphisms in men with coronary artery disease. J Clin Endocrinol Metab (2004) 1.02
Soft tissue penetration of cefuroxime determined by clinical microdialysis in morbidly obese patients undergoing abdominal surgery. Int J Antimicrob Agents (2009) 1.01
Gender differences in presentation and diagnosis of chest pain in primary care. BMC Fam Pract (2009) 1.01
Profiling of secondary metabolites in root exudates of Arabidopsis thaliana. Phytochemistry (2014) 0.99
Prevalence of the parvovirus B19 genome in endomyocardial biopsy specimens. Hum Pathol (2003) 0.99
Importance of relating efficacy measures to unbound drug concentrations for anti-infective agents. Clin Microbiol Rev (2013) 0.99
Contribution of comorbidities to functional impairment is higher in heart failure with preserved than with reduced ejection fraction. Clin Res Cardiol (2011) 0.98
Detection of Porphyromonas gingivalis DNA in aortic tissue by PCR. J Periodontol (2002) 0.98
Clinical and immunologic characteristics in peripartum cardiomyopathy. Int J Cardiol (2006) 0.97
Reduced subcutaneous tissue distribution of cefazolin in morbidly obese versus non-obese patients determined using clinical microdialysis. J Antimicrob Chemother (2013) 0.96
Clinical pharmacokinetics and pharmacodynamics of tigecycline. Clin Pharmacokinet (2009) 0.96
Management strategies in pericardial emergencies. Herz (2006) 0.96
Activated nuclear transcription factor kappaB in patients with myocarditis and dilated cardiomyopathy--relation to inflammation and cardiac function. Biochem Biophys Res Commun (2005) 0.96
Right ventricular cardiac myxoma. Diagnostic usefulness of cardiac magnetic resonance imaging. Herz (2005) 0.95
A missense variant in desmoglein-2 predisposes to dilated cardiomyopathy. Mol Genet Metab (2008) 0.95
The use of partial fatty acid oxidation inhibitors for metabolic therapy of angina pectoris and heart failure. Herz (2002) 0.94
Pericardial syndromes: an update after the ESC guidelines 2004. Heart Fail Rev (2013) 0.93
Economic burden of patients with various etiologies of chronic systolic heart failure analyzed by resource use and costs. Int J Cardiol (2012) 0.93
Parvovirus B19 genome in endomyocardial biopsy specimen. Circulation (2004) 0.93
Chest wall syndrome in primary care patients with chest pain: presentation, associated features and diagnosis. Fam Pract (2010) 0.92
A pharmacokinetic/pharmacodynamic mathematical model accurately describes the activity of voriconazole against Candida spp. in vitro. Int J Antimicrob Agents (2008) 0.92
A genome-wide association study identifies 6p21 as novel risk locus for dilated cardiomyopathy. Eur Heart J (2013) 0.92
Evaluation of quantitative ultrasound tissue characterization of the cervix and cervical length in the prediction of premature delivery for patients with spontaneous preterm labor. Am J Obstet Gynecol (2003) 0.91
Gender bias revisited: new insights on the differential management of chest pain. BMC Fam Pract (2011) 0.91
Novel point mutations in the mitochondrial DNA detected in patients with dilated cardiomyopathy by screening the whole mitochondrial genome. Biochem Biophys Res Commun (2004) 0.91
Periodontal microbiota in patients with coronary artery disease measured by real-time polymerase chain reaction: a case-control study. J Periodontol (2007) 0.90
Acute parvovirus B19 infection associated with myocarditis in an immunocompetent adult. Hum Pathol (2003) 0.90
Penetration of ertapenem into skeletal muscle and subcutaneous adipose tissue in healthy volunteers measured by in vivo microdialysis. J Antimicrob Chemother (2006) 0.90
Discriminatory features of acute transverse myelitis: a retrospective analysis of 45 patients. J Neurol Sci (2004) 0.90
[2015 ESC Guidelines for the diagnosis and management of pericardial diseases]. Kardiol Pol (2015) 0.89
Sudden cardiac death in dilated cardiomyopathy -- therapeutic options. Herz (2002) 0.89
Underdosing of ertapenem in critically ill patients with pneumonia confirmed by Monte Carlo simulations. Int J Antimicrob Agents (2009) 0.89
In vivo stable-isotope kinetic study suggests intracellular assembly of lipoprotein(a). Atherosclerosis (2012) 0.89
Increased end diastolic wall stress precedes left ventricular hypertrophy in dilative heart failure--use of the volume-based wall stress index. Int J Cardiol (2011) 0.89
Antitachycardia pacing for spontaneous rapid ventricular tachycardia in patients with prophylactic cardioverter-defibrillator therapy. Pacing Clin Electrophysiol (2006) 0.89
A network against failing hearts--introducing the German "Competence Network Heart Failure". Int J Cardiol (2009) 0.88
Carbohydrate-lectin recognition of sequence-defined heteromultivalent glycooligomers. J Am Chem Soc (2014) 0.88
Novel mutations in the sarcomeric protein myopalladin in patients with dilated cardiomyopathy. Eur J Hum Genet (2012) 0.88
Computer-assisted detection of pulmonary embolism: performance evaluation in consensus with experienced and inexperienced chest radiologists. Eur Radiol (2007) 0.88
Pericardial cytokines in neoplastic, autoreactive, and viral pericarditis. Heart Fail Rev (2013) 0.88
Activation of STAT1 transcription factor precedes up-regulation of coxsackievirus-adenovirus receptor during viral myocarditis. Cardiovasc Pathol (2007) 0.88
Prognostic significance of heart rate turbulence following ventricular premature beats in patients with idiopathic dilated cardiomyopathy. J Cardiovasc Electrophysiol (2003) 0.87
Mechanisms involved in the differential reduction of omega-3 and omega-6 highly unsaturated fatty acids by structural heart disease resulting in "HUFA deficiency". Can J Physiol Pharmacol (2011) 0.87
Delayed in vivo catabolism of intermediate-density lipoprotein and low-density lipoprotein in hemodialysis patients as potential cause of premature atherosclerosis. Arterioscler Thromb Vasc Biol (2005) 0.87
Anti-S-nitrosocysteine antibodies are a predictive marker for demyelination in experimental autoimmune encephalomyelitis: implications for multiple sclerosis. J Neurosci (2002) 0.87
Molecular mechanisms involved in atherosclerosis. Herz (2002) 0.86
Recurrent pericarditis: mysterious or not so mysterious? Eur Heart J (2005) 0.86
Osteoprotegerin expression in dendritic cells increases with maturation and is NF-kappaB-dependent. J Cell Biochem (2007) 0.86
Colesevelam added to combination therapy with a statin and ezetimibe in patients with familial hypercholesterolemia: a 12-week, multicenter, randomized, double-blind, controlled trial. Clin Ther (2010) 0.86
N-3 polyunsaturated fatty acids and statins in heart failure. Lancet (2009) 0.86
Glycosylphosphatidylinositol-induced cardiac myocyte death might contribute to the fatal outcome of Plasmodium falciparum malaria. Apoptosis (2008) 0.86
Clinical pharmacokinetics and pharmacodynamics of clopidogrel. Clin Pharmacokinet (2015) 0.86